SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Global Cord Blood Corporation (NYSE:CO) securities between June 4, 2019 and May 3, 2022. Global Cord Blood provides umbilical cord blood storage and ancillary services in the Beijing Municipality, Guangdong Province, and Zhejiang Province of the People's Republic of China.
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
The Allegations: Robbins LLP is Investigating the Allegations that the Board of Global Cord Blood Corporation (CO) Engaged in Self-Serving and Conflicted Transactions
According to the complaint, during the class period, Defendants failed to disclose that: (i) Global Cord employed a capital allocation strategy designed to reserve funds for Company insiders and related parties rather than for the benefit of ...